Thomas Steyer’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Thomas Steyer’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Sell	40,000 -314,000	-89%	-$10.5M	0.01%	76
2026 Q1	$10.7M	Buy	354,000 +314,000	+785%	+$10.1M	0.06%	67
2025 Q4	$1.25M	Sell	40,000 -4,957,000	-99%	-$122M	0.01%	84
2025 Q3	$101M	Buy	+4,997,000	New	+$87.8M	0.41%	45

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Thomas Steyer's TEVA Position: Q2 2026 in Review

Thomas Steyer reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 89% in Q2 2026, selling an estimated $10.5M and leaving 40,000 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #76.

Thomas Steyer first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $101M in Q3 2025. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Thomas Steyer held 40,000 shares of Teva Pharmaceutical Industries Limited worth $1.36M as of Q2 2026.
Thomas Steyer sold 314,000 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $10.5M.
Teva Pharmaceutical Industries Limited made up 0.01% of Thomas Steyer's portfolio in Q2 2026, its #76 holding.
Thomas Steyer first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 4 quarters since.
Thomas Steyer's Teva Pharmaceutical Industries Limited position peaked at $101M in Q3 2025.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.